Thrive Capital leads Isomorphic Labs Series B

Isomorphic Labs announced Series B funding led by Thrive Capital, with Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund participating. The company said the financing would help scale its AI drug-design work. Thrive's individual investment amount was not disclosed.